$CHCI
Comstock Holding Companies, Inc.

2022 Q1 Form 10-Q Financial Statement

#000129996922000023 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $8.731M $6.840M
YoY Change 27.65% -1.81%
Cost Of Revenue $6.935M $6.078M
YoY Change 14.1% 1.3%
Gross Profit $1.796M $1.152M
YoY Change 55.9% 3.04%
Gross Profit Margin 20.57% 16.84%
Selling, General & Admin $387.0K $299.0K
YoY Change 29.43% -67.75%
% of Gross Profit 21.55% 25.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $44.00K $20.00K
YoY Change 120.0% -69.23%
% of Gross Profit 2.45% 1.74%
Operating Expenses $387.0K $299.0K
YoY Change 29.43% -67.75%
Operating Profit $1.365M $443.0K
YoY Change 208.13% 131.94%
Interest Expense $193.0K $0.00
YoY Change -100.0%
% of Operating Profit 14.14% 0.0%
Other Income/Expense, Net $0.00 $1.000K
YoY Change -100.0% -100.61%
Pretax Income $1.558M $392.0K
YoY Change 297.45% 988.89%
Income Tax -$456.0K $2.000K
% Of Pretax Income -29.27% 0.51%
Net Earnings $1.747M $247.0K
YoY Change 607.29% -2158.33%
Net Earnings / Revenue 20.01% 3.61%
Basic Earnings Per Share $0.21 $0.03
Diluted Earnings Per Share $0.19 $0.03
COMMON SHARES
Basic Shares Outstanding 8.340M shares 8.166M shares
Diluted Shares Outstanding 8.974M shares 8.997M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.56M $6.700M
YoY Change 72.54% -6.94%
Cash & Equivalents $11.56M $6.657M
Short-Term Investments
Other Short-Term Assets $415.0K $300.0K
YoY Change 38.33% -25.0%
Inventory
Prepaid Expenses
Receivables $802.0K $1.437M
Other Receivables $0.00
Total Short-Term Assets $15.28M $13.34M
YoY Change 14.53% 7.31%
LONG-TERM ASSETS
Property, Plant & Equipment $7.669M $242.0K
YoY Change 3069.01% 1.26%
Goodwill $1.700M
YoY Change -0.12%
Intangibles
YoY Change
Long-Term Investments $7.490M $4.700M
YoY Change 59.36% -42.68%
Other Assets $15.07M
YoY Change
Total Long-Term Assets $27.02M $14.38M
YoY Change 87.9% 38.83%
TOTAL ASSETS
Total Short-Term Assets $15.28M $13.34M
Total Long-Term Assets $27.02M $14.38M
Total Assets $42.30M $27.72M
YoY Change 52.59% 21.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.104M $692.0K
YoY Change 59.54% 16.69%
Accrued Expenses $8.805M $1.221M
YoY Change 621.13% 103.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $100.0K
YoY Change -100.0% -3.85%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.165M $3.551M
YoY Change -10.87% -52.87%
LONG-TERM LIABILITIES
Long-Term Debt $5.500M $5.500M
YoY Change 0.0% -17.91%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $5.500M $5.500M
YoY Change 0.0% -17.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.165M $3.551M
Total Long-Term Liabilities $5.500M $5.500M
Total Liabilities $15.41M $16.26M
YoY Change -5.25% 14.18%
SHAREHOLDERS EQUITY
Retained Earnings -$177.8M -$192.9M
YoY Change -7.83% -1.2%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.662M
YoY Change
Treasury Stock Shares 86.00K shares
Shareholders Equity $26.89M $11.46M
YoY Change
Total Liabilities & Shareholders Equity $42.30M $27.72M
YoY Change 52.59% 21.58%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $1.747M $247.0K
YoY Change 607.29% -2158.33%
Depreciation, Depletion And Amortization $44.00K $20.00K
YoY Change 120.0% -69.23%
Cash From Operating Activities -$2.154M -$1.923M
YoY Change 12.01% 0.79%
INVESTING ACTIVITIES
Capital Expenditures -$163.0K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.622M $1.700M
YoY Change -195.41% 1600.0%
Cash From Investing Activities -$1.785M $1.652M
YoY Change -208.05% 1123.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -324.0K -$104.0K
YoY Change 211.54% -101.91%
NET CHANGE
Cash From Operating Activities -2.154M -$1.923M
Cash From Investing Activities -1.785M $1.652M
Cash From Financing Activities -324.0K -$104.0K
Net Change In Cash -$4.263M -$375.0K
YoY Change 1036.8% -110.22%
FREE CASH FLOW
Cash From Operating Activities -$2.154M -$1.923M
Capital Expenditures -$163.0K $0.00
Free Cash Flow -$1.991M -$1.923M
YoY Change 3.54% 0.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001299969
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
1-32375
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Comstock Holding Companies, Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1164345
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1900 Reston Metro Plaza
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
10th Floor
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Reston
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20190
CY2022Q1 dei City Area Code
CityAreaCode
703
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
230-1985
CY2022Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.01 par value
CY2022Q1 dei Trading Symbol
TradingSymbol
CHCI
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11560000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15823000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
802000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46000 USD
CY2022Q1 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
2505000 USD
CY2021Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
1697000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
415000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
197000 USD
CY2022Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
2313000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
15282000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
20076000 USD
CY2022Q1 chci Property Plant And Equipment Net Excluding Leasehold Improvements
PropertyPlantAndEquipmentNetExcludingLeaseholdImprovements
389000 USD
CY2021Q4 chci Property Plant And Equipment Net Excluding Leasehold Improvements
PropertyPlantAndEquipmentNetExcludingLeaseholdImprovements
264000 USD
CY2022Q1 chci Leasehold Improvements Net
LeaseholdImprovementsNet
119000 USD
CY2021Q4 chci Leasehold Improvements Net
LeaseholdImprovementsNet
0 USD
CY2022Q1 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
7490000 USD
CY2021Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
4702000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7161000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7245000 USD
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11766000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11300000 USD
CY2022Q1 us-gaap Other Assets
OtherAssets
90000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
15000 USD
CY2022Q1 us-gaap Assets
Assets
42297000 USD
CY2021Q4 us-gaap Assets
Assets
43602000 USD
CY2022Q1 chci Accrued Personnel Costs
AccruedPersonnelCosts
1394000 USD
CY2021Q4 chci Accrued Personnel Costs
AccruedPersonnelCosts
3468000 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1104000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
783000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
667000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
616000 USD
CY2022Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1194000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3165000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6061000 USD
CY2022Q1 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
5500000 USD
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
5500000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6744000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6745000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
15409000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
18306000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
200461000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
200617000 USD
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
86000 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
86000 shares
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2662000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2662000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-177760000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-179507000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
26888000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25296000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42297000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43602000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8731000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6840000 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
6935000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
6078000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
387000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
299000 USD
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
44000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
20000 USD
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
7366000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
6397000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1365000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
443000 USD
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-59000 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-58000 USD
CY2022Q1 chci Change In Fair Value Of Equity Method Investment
ChangeInFairValueOfEquityMethodInvestment
-252000 USD
CY2021Q1 chci Change In Fair Value Of Equity Method Investment
ChangeInFairValueOfEquityMethodInvestment
-6000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1558000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
392000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-456000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2014000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
390000 USD
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-267000 USD
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-143000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1747000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
247000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8340000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8166000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8974000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8997000 shares
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.24
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.05
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.22
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.05
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25296000 USD
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-297000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
142000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1747000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
26888000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11215000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-187000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
183000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
247000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11458000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2014000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
390000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
197000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
153000 USD
CY2022Q1 chci Gain Loss On Equity Method Investments Carried At Fair Value
GainLossOnEquityMethodInvestmentsCarriedAtFairValue
252000 USD
CY2021Q1 chci Gain Loss On Equity Method Investments Carried At Fair Value
GainLossOnEquityMethodInvestmentsCarriedAtFairValue
6000 USD
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-456000 USD
CY2021Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1689000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1218000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
218000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
92000 USD
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2074000 USD
CY2021Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1455000 USD
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
322000 USD
CY2021Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
142000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-160000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-26000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1952000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2040000 USD
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2656000 USD
CY2021Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
CY2022Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
1016000 USD
CY2021Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2022Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
18000 USD
CY2021Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1660000 USD
CY2022Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
163000 USD
CY2021Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
7000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1785000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1653000 USD
CY2022Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
121000 USD
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
30000 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
297000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
196000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-297000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-105000 USD
CY2022Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-202000 USD
CY2021Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
117000 USD
CY2022Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0 USD
CY2021Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0 USD
CY2022Q1 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-27000 USD
CY2021Q1 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-229000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
117000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4263000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-375000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15823000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7032000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11560000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6657000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
59000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
58000 USD
CY2022Q1 us-gaap Stock Issued1
StockIssued1
0 USD
CY2021Q1 us-gaap Stock Issued1
StockIssued1
7000 USD
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
209000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Significant items subject to such estimates, include, but are not limited to, the valuation of equity method investments and the valuation of deferred tax assets. Assumptions made in the development of these estimates contemplate the macroeconomic landscape and the Company's anticipated results, however actual results may differ materially from these estimates.
CY2022Q1 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
7490000 USD
CY2021Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
4702000 USD
CY2019Q2 chci Proceed From Sale Of Investment Percentage Of Profit
ProceedFromSaleOfInvestmentPercentageOfProfit
0.50
CY2022Q1 chci Proportionate Share Of Net Income And Distributions Amount
ProportionateShareOfNetIncomeAndDistributionsAmount
-100000 USD
CY2021Q1 chci Proportionate Share Of Net Income And Distributions Amount
ProportionateShareOfNetIncomeAndDistributionsAmount
0 USD
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
240000 USD
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
223000 USD
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
86000 USD
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
75000 USD
CY2022Q1 us-gaap Lease Cost
LeaseCost
326000 USD
CY2021Q1 us-gaap Lease Cost
LeaseCost
298000 USD
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
160000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
139000 USD
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y8M1D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0425
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
723000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
985000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1008000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1031000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1054000 USD
CY2022Q1 chci Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
4091000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8892000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1481000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
7411000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1400000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
397000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.89
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M12D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1054000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
998000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
30000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.71
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.24
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
46000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
4.48
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
318000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.78
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M6D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1122000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
298000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.78
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y8M12D
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8731000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6840000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8731000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6840000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8731000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6840000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-500000 USD
CY2022Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-700000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2014000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
390000 USD
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-267000 USD
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-143000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8340000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8166000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
634000 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
831000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8974000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8997000 shares
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.24
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.05
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.22
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.05
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03

Files In Submission

Name View Source Status
0001299969-22-000023-index-headers.html Edgar Link pending
0001299969-22-000023-index.html Edgar Link pending
0001299969-22-000023.txt Edgar Link pending
0001299969-22-000023-xbrl.zip Edgar Link pending
a2022_0101xrsffxparkxlea.htm Edgar Link pending
a2022_0101xrsffxparkxlea001.jpg Edgar Link pending
a2022_0101xrsffxparkxlea002.jpg Edgar Link pending
a2022_0101xrsffxparkxlea003.jpg Edgar Link pending
a2022_0101xrsffxparkxlea004.jpg Edgar Link pending
a2022_0101xrsffxparkxlea005.jpg Edgar Link pending
a2022_0101xrsffxparkxlea006.jpg Edgar Link pending
a2022_0101xrsffxparkxlea007.jpg Edgar Link pending
a2022_0101xrsffxparkxlea008.jpg Edgar Link pending
a2022_0101xrsffxparkxlea009.jpg Edgar Link pending
a2022_0101xrsffxparkxlea010.jpg Edgar Link pending
a2022_0101xrsffxparkxlea011.jpg Edgar Link pending
a2022_0101xrsffxparkxlea012.jpg Edgar Link pending
a2022_0101xrsffxparkxlea013.jpg Edgar Link pending
a2022_0101xrsffxparkxlea014.jpg Edgar Link pending
a2022_0101xrsffxparkxlea015.jpg Edgar Link pending
a2022_0101xrsffxparkxlea016.jpg Edgar Link pending
a2022_0101xrsffxparkxlea017.jpg Edgar Link pending
a2022_0101xrsffxparkxlea018.jpg Edgar Link pending
a2022_0101xrsffxparkxlea019.jpg Edgar Link pending
a2022_0101xrsffxparkxlea020.jpg Edgar Link pending
a2022_0101xrsffxparkxlea021.jpg Edgar Link pending
a2022_0101xrsffxparkxlea022.jpg Edgar Link pending
a2022_0101xrsffxparkxlea023.jpg Edgar Link pending
a2022_0101xrsffxparkxlea024.jpg Edgar Link pending
a2022_0101xrsffxparkxlea025.jpg Edgar Link pending
a2022_0101xrsffxparkxlea026.jpg Edgar Link pending
a2022_0101xrsffxparkxlea027.jpg Edgar Link pending
a2022_0101xrsffxparkxlea028.jpg Edgar Link pending
a2022_0101xrsffxparkxlea029.jpg Edgar Link pending
a2022_0101xrsffxparkxlea030.jpg Edgar Link pending
a2022_0101xrsffxparkxlea031.jpg Edgar Link pending
a2022_0101xrsffxparkxlea032.jpg Edgar Link pending
a2022_0101xrsffxparkxlea033.jpg Edgar Link pending
a2022_0101xrsffxparkxlea034.jpg Edgar Link pending
a2022_0101xrsffxparkxlea035.jpg Edgar Link pending
a2022_0101xrsffxparkxlea036.jpg Edgar Link pending
a2022_0101xrsffxparkxlea037.jpg Edgar Link pending
a2022_0101xrsffxparkxlea038.jpg Edgar Link pending
a2022_0101xrsffxparkxlea039.jpg Edgar Link pending
a2022_0101xrsffxparkxlea040.jpg Edgar Link pending
a2022_0101xrsffxparkxlea041.jpg Edgar Link pending
a2022_0101xrsffxparkxlea042.jpg Edgar Link pending
a2022_0101xrsffxparkxlea043.jpg Edgar Link pending
a2022_0101xrsffxparkxlea044.jpg Edgar Link pending
a2022_0101xrsffxparkxlea045.jpg Edgar Link pending
a2022_0101xrsffxparkxlea046.jpg Edgar Link pending
a2022_0101xrsffxparkxlea047.jpg Edgar Link pending
a2022_0101xrsffxparkxlea048.jpg Edgar Link pending
a2022_0101xrsffxparkxlea049.jpg Edgar Link pending
a2022_0101xrsffxparkxlea050.jpg Edgar Link pending
a2022_0101xrsffxparkxlea051.jpg Edgar Link pending
a2022_0101xrsffxparkxlea052.jpg Edgar Link pending
a2022_0101xrsffxparkxlea053.jpg Edgar Link pending
a2022_0321xanselxcomstoc.htm Edgar Link pending
a2022_0321xanselxcomstoc001.jpg Edgar Link pending
a2022_0321xanselxcomstoc002.jpg Edgar Link pending
a2022_0321xanselxcomstoc003.jpg Edgar Link pending
a2022_0321xanselxcomstoc004.jpg Edgar Link pending
a2022_0321xanselxcomstoc005.jpg Edgar Link pending
a2022_0321xanselxcomstoc006.jpg Edgar Link pending
a2022_0321xanselxcomstoc007.jpg Edgar Link pending
a2022_0321xanselxcomstoc008.jpg Edgar Link pending
a2022_0321xanselxcomstoc009.jpg Edgar Link pending
a2022_0321xanselxcomstoc010.jpg Edgar Link pending
a2022_0321xanselxcomstoc011.jpg Edgar Link pending
a2022_0321xanselxcomstoc012.jpg Edgar Link pending
a2022_0321xanselxcomstoc013.jpg Edgar Link pending
a2022_0321xanselxcomstoc014.jpg Edgar Link pending
a2022_0321xanselxcomstoc015.jpg Edgar Link pending
a2022_0321xanselxcomstoc016.jpg Edgar Link pending
a2022_0321xanselxcomstoc017.jpg Edgar Link pending
a2022_0321xanselxcomstoc018.jpg Edgar Link pending
a2022_0321xanselxcomstoc019.jpg Edgar Link pending
a2022_0321xanselxcomstoc020.jpg Edgar Link pending
a2022_0321xanselxcomstoc021.jpg Edgar Link pending
a2022_0321xanselxcomstoc022.jpg Edgar Link pending
a2022_0321xanselxcomstoc023.jpg Edgar Link pending
a2022_0321xanselxcomstoc024.jpg Edgar Link pending
a2022_0321xanselxcomstoc025.jpg Edgar Link pending
a2022_0321xanselxcomstoc026.jpg Edgar Link pending
a2022_0321xanselxcomstoc027.jpg Edgar Link pending
a2022_0321xanselxcomstoc028.jpg Edgar Link pending
a2022_0321xanselxcomstoc029.jpg Edgar Link pending
augustmackcomstock-asset.htm Edgar Link pending
augustmackcomstock-asset001.jpg Edgar Link pending
augustmackcomstock-asset002.jpg Edgar Link pending
augustmackcomstock-asset003.jpg Edgar Link pending
augustmackcomstock-asset004.jpg Edgar Link pending
augustmackcomstock-asset005.jpg Edgar Link pending
augustmackcomstock-asset006.jpg Edgar Link pending
augustmackcomstock-asset007.jpg Edgar Link pending
augustmackcomstock-asset008.jpg Edgar Link pending
augustmackcomstock-asset009.jpg Edgar Link pending
augustmackcomstock-asset010.jpg Edgar Link pending
augustmackcomstock-asset011.jpg Edgar Link pending
augustmackcomstock-asset012.jpg Edgar Link pending
augustmackcomstock-asset013.jpg Edgar Link pending
augustmackcomstock-asset014.jpg Edgar Link pending
augustmackcomstock-asset015.jpg Edgar Link pending
augustmackcomstock-asset016.jpg Edgar Link pending
augustmackcomstock-asset017.jpg Edgar Link pending
augustmackcomstock-asset018.jpg Edgar Link pending
augustmackcomstock-asset019.jpg Edgar Link pending
augustmackcomstock-asset020.jpg Edgar Link pending
augustmackcomstock-asset021.jpg Edgar Link pending
augustmackcomstock-asset022.jpg Edgar Link pending
augustmackcomstock-asset023.jpg Edgar Link pending
augustmackcomstock-asset024.jpg Edgar Link pending
augustmackcomstock-asset025.jpg Edgar Link pending
augustmackcomstock-asset026.jpg Edgar Link pending
augustmackcomstock-asset027.jpg Edgar Link pending
augustmackcomstock-asset028.jpg Edgar Link pending
augustmackcomstock-asset029.jpg Edgar Link pending
augustmackcomstock-asset030.jpg Edgar Link pending
augustmackcomstock-asset031.jpg Edgar Link pending
augustmackcomstock-asset032.jpg Edgar Link pending
augustmackcomstock-asset033.jpg Edgar Link pending
augustmackcomstock-asset034.jpg Edgar Link pending
augustmackcomstock-asset035.jpg Edgar Link pending
augustmackcomstock-asset036.jpg Edgar Link pending
augustmackcomstock-asset037.jpg Edgar Link pending
augustmackcomstock-asset038.jpg Edgar Link pending
augustmackcomstock-asset039.jpg Edgar Link pending
augustmackcomstock-asset040.jpg Edgar Link pending
augustmackcomstock-asset041.jpg Edgar Link pending
augustmackcomstock-asset042.jpg Edgar Link pending
augustmackcomstock-asset043.jpg Edgar Link pending
augustmackcomstock-asset044.jpg Edgar Link pending
augustmackcomstock-asset045.jpg Edgar Link pending
augustmackcomstock-asset046.jpg Edgar Link pending
augustmackcomstock-asset047.jpg Edgar Link pending
augustmackcomstock-asset048.jpg Edgar Link pending
augustmackcomstock-asset049.jpg Edgar Link pending
augustmackcomstock-asset050.jpg Edgar Link pending
augustmackcomstock-asset051.jpg Edgar Link pending
augustmackcomstock-asset052.jpg Edgar Link pending
augustmackcomstock-asset053.jpg Edgar Link pending
augustmackcomstock-asset054.jpg Edgar Link pending
augustmackcomstock-asset055.jpg Edgar Link pending
augustmackcomstock-asset056.jpg Edgar Link pending
augustmackcomstock-asset057.jpg Edgar Link pending
augustmackcomstock-asset058.jpg Edgar Link pending
augustmackcomstock-asset059.jpg Edgar Link pending
augustmackcomstock-asset060.jpg Edgar Link pending
chci-20220331.htm Edgar Link pending
chci-20220331.xsd Edgar Link pending
chci-20220331_cal.xml Edgar Link unprocessable
chci-20220331_def.xml Edgar Link unprocessable
chci-20220331_htm.xml Edgar Link completed
chci-20220331_lab.xml Edgar Link unprocessable
chci-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q12210-qex311.htm Edgar Link pending
q12210-qex312.htm Edgar Link pending
q12210-qex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending